Latest Neuro Protection Company Stories

2008-08-28 18:00:19

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Aug. 28, 2008) - Allon Therapeutics Inc. (TSX:NPC) announced today that in a Phase IIa clinical trial evaluating the potential of its drug AL-208 to prevent or reduce mild cognitive impairment (MCI) in patients who undergo coronary artery bypass graft (CABG) surgery the single-dose had no observable effect in these patients. Neither the placebo nor the treated groups appeared significantly impaired in their cognitive functions post surgery in...

2008-07-30 12:00:21

CHICAGO, ILLINOIS--(Marketwire - July 30, 2008) - Allon Therapeutics Inc. (TSX:NPC) - Clinical trial data presented today to two scientific workshops at the International Conference on Alzheimer's Disease and Related Disorders (ICAD 2008) validate the therapeutic potential of addressing the "tangles" component of the classic Alzheimer's "plaques and tangles" pathology. The data from a clinical trial evaluating drug candidate AL-108 in 144 patients with amnestic mild cognitive impairment...

2008-07-28 15:00:22

CHICAGO, ILLINOIS--(Marketwire - July 28, 2008) - Allon Therapeutics Inc. (TSX:NPC) - A potential new treatment for Alzheimer's disease that reduces the classic Alzheimer's "tangle" pathology in mice has also improved specific memory function in humans with amnestic mild cognitive impairment (aMCI), a precursor to Alzheimer's disease, according to a presentation today at a news conference hosted by the Alzheimer's Association at their International Conference on Alzheimer's Disease and...

Word of the Day
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.